Bumrungrad International Hospital is at the forefront of personalized cancer care with comprehensive genomic testing that leads to a more accurate diagnosis and better analysis of outcomes for cancer patients.
Bumrungrad, a medical tourism and healthcare leader for over a decade, was Asia’s first hospital to be accredited by Joint Commission International (JCI) for American-equivalent clinical operations standards in 2002. A one-stop-shop of multidisciplinary medicine, Bumrungrad provides comprehensive care in over 70 clinical sub-specialties for patients from over 190 nationalities and underlined its pioneering position in cancer treatment with commitment to the latest innovations in cancer prevention, treatment, and research.
New comprehensive genomic profiling includes an updated gene list and alterations in the most commonly mutated genes known to drive the growth of cancer. New tests detail genomic signatures which can better direct treatment decisions. Since all patients are different, specific individual treatments, often called targeted therapies or precision medicine, are customized to each patient and can be more effective than standard cancer treatments.
Dr. Surasit Issarachai, an Oncology Specialist at Horizon Regional Cancer Center, Bumrungrad International Hospital, stated that today’s technology makes diagnosis faster and more accurate, which is vital since cancer is the leading cause of death in most developed countries.
Dr. Issarachai, who is also fluent in Arabic, said that it is a misconception that cancer is mostly hereditary, and that personalized cancer treatment is better in many cases.
“Everybody has a different genetic make-up which makes us susceptible to different diseases therefore medication can work in different ways for different people. In some cases, we can use targeted therapy to help control the cancer,” he said. “While standard treatments are still effective; some cases require greater insights. This is where the new technology that helps assess genes can help improve treatments for some patients by FoundationOne CDx, the first broad companion diagnostic assay to be endorsed by the USFDA, has been launched by Roche and Bumrungrad at the forefront of genomic testing in Thailand.”
Bumrungrad International is one of the hospitals outside of the United States to utilize an advance machine learning AI supporting Doctors in diagnoses and treatment plans with the aggregation of all past and current clinical trial and research data for oncology.
Archive
- October 2024(44)
- September 2024(94)
- August 2024(100)
- July 2024(99)
- June 2024(126)
- May 2024(155)
- April 2024(123)
- March 2024(112)
- February 2024(109)
- January 2024(95)
- December 2023(56)
- November 2023(86)
- October 2023(97)
- September 2023(89)
- August 2023(101)
- July 2023(104)
- June 2023(113)
- May 2023(103)
- April 2023(93)
- March 2023(129)
- February 2023(77)
- January 2023(91)
- December 2022(90)
- November 2022(125)
- October 2022(117)
- September 2022(137)
- August 2022(119)
- July 2022(99)
- June 2022(128)
- May 2022(112)
- April 2022(108)
- March 2022(121)
- February 2022(93)
- January 2022(110)
- December 2021(92)
- November 2021(107)
- October 2021(101)
- September 2021(81)
- August 2021(74)
- July 2021(78)
- June 2021(92)
- May 2021(67)
- April 2021(79)
- March 2021(79)
- February 2021(58)
- January 2021(55)
- December 2020(56)
- November 2020(59)
- October 2020(78)
- September 2020(72)
- August 2020(64)
- July 2020(71)
- June 2020(74)
- May 2020(50)
- April 2020(71)
- March 2020(71)
- February 2020(58)
- January 2020(62)
- December 2019(57)
- November 2019(64)
- October 2019(25)
- September 2019(24)
- August 2019(14)
- July 2019(23)
- June 2019(54)
- May 2019(82)
- April 2019(76)
- March 2019(71)
- February 2019(67)
- January 2019(75)
- December 2018(44)
- November 2018(47)
- October 2018(74)
- September 2018(54)
- August 2018(61)
- July 2018(72)
- June 2018(62)
- May 2018(62)
- April 2018(73)
- March 2018(76)
- February 2018(8)
- January 2018(7)
- December 2017(6)
- November 2017(8)
- October 2017(3)
- September 2017(4)
- August 2017(4)
- July 2017(2)
- June 2017(5)
- May 2017(6)
- April 2017(11)
- March 2017(8)
- February 2017(16)
- January 2017(10)
- December 2016(12)
- November 2016(20)
- October 2016(7)
- September 2016(102)
- August 2016(168)
- July 2016(141)
- June 2016(149)
- May 2016(117)
- April 2016(59)
- March 2016(85)
- February 2016(153)
- December 2015(150)